Potassium voltage-gated channel subfamily C member 2 and Potassium voltage-gated channel subfamily C member 4 (Kv3.2/Kv3.4)

Potassium voltage-gated channel subfamily C member 2 (Kv3.2) and member 4 (Kv3.4) are specialized ion channels essential for high-frequency neuronal firing in the central and peripheral nervous systems [1, 2]. These channels are characterized by high activation thresholds and exceptionally fast gating kinetics, which allow for the rapid repolarization of action potentials without increasing the refractory period [2, 15]. Kv3.2 is primarily expressed in the brain, particularly in the thalamus and cortex, where it regulates the excitability of fast-spiking GABAergic interneurons [1, 10]. Kv3.4 is found in both the brain and peripheral tissues, such as the dorsal root ganglia and skeletal muscle, where it contributes to nociceptive signaling and the regulation of neurotransmitter release [7, 17]. Dysregulation of these channels is linked to various neurological and psychiatric conditions, including schizophrenia, Alzheimer's disease, epilepsy, and chronic pain [1, 3, 10]. Therapeutic strategies involve the use of positive allosteric modulators to restore high-frequency firing in impaired circuits or inhibitors to modulate pain signaling [1, 10, 17]. Notable pharmacological agents include the sea anemone toxins BDS-I and BDS-II, which block these channels, and investigational small molecules like AUT00063 and AUT00206 [3, 10]. Safety considerations for targeting these channels include the risk of inducing seizures or motor coordination issues due to their critical role in inhibitory circuit balance [1, 8, 10]. Biomarkers such as EEG gamma oscillations and auditory evoked potentials are often used to monitor the efficacy of Kv3 modulators in clinical settings [10]. Overall, Kv3.2 and Kv3.4 represent promising targets for fine-tuning neuronal excitability in complex brain disorders [1, 2].

Other names

KCNC2KCNC4Shaw-related subfamily member 2Shaw-related subfamily member 4KV3.2KV3.4

Positive allosteric modulation to enhance channel opening and high-frequency firing, or channel blockade to reduce potassium efflux and prolong action potentials.